Advertisement

Neuroradiology

, Volume 59, Issue 4, pp 323–324 | Cite as

Spontaneous subdural hematomas particularly with a decreased coagulation factor XIII activity require follow-ups of the neuroradiological diagnostic

  • Bert BoscheEmail author
  • Bastian Kraus
  • Marek Molcanyi
Letter to the Editor
  • 135 Downloads

Keywords

Subdural Hematoma Chronic Subdural Hematoma Thunderclap Headache Factor Xiii Activity Brain Stem Compression 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Notes

Compliance with ethical standards

Funding

This work was supported by grants of the Deutsche Forschungsgemeinschaft (DFG) to BB (Grant Numbers: BO 4229/1-1, BO 4229/2-1, Novel strategies to protect the neurovascular unit in cerebrovascular diseases).

Conflict of interest

BB is a member of the scientific advisory board of Edge Therapeutics and has received a travel grant, speaker honorarium and material support from CSL Behring, Germany and Canada.

Ethical approval

For this type of study formal consent is not required.

Informed consent

Statement of informed consent was not applicable since the manuscript does not contain any patient data.

References

  1. 1.
    Han Z, Du Y, Qi H (2016) Yin, W. Massive spontaneous parasellar and retroclival subdural hematoma Neuroradiology 58:321–324. doi: 10.1007/s00234-015-1632-3 PubMedGoogle Scholar
  2. 2.
    Bosche B, Molcanyi M, Krause B et al (2013) Occurrence and recurrence of spontaneous chronic subdural haematoma is associated with a factor XIII deficiency. Clin Neurol Neurosurg 115:13–18. doi: 10.1016/j.clineuro.2012.03.045 CrossRefPubMedGoogle Scholar
  3. 3.
    Narvid J, Amans MR, Cooke DL et al (2016) Spontaneous retroclival hematoma: a case series. J Neurosurg 124:716–719. doi: 10.3171/2015.2.JNS142221 CrossRefPubMedGoogle Scholar
  4. 4.
    Pieters M, Covic N, van der Westhuizen FH et al (2008) Glycaemic control improves fibrin network characteristics in type 2 diabetes – a purified fibrinogen model. Thromb Haemost 99:691–700. doi: 10.1160/TH07-11-0699 PubMedPubMedCentralGoogle Scholar
  5. 5.
    Solomon C, Korte W, Fries D et al (2016) Safety of factor XIII concentrate: analysis of more than 20 years of pharmacovigilance data. Transfus Med Hemother 43:365–373. doi: 10.1159/000446813 CrossRefPubMedPubMedCentralGoogle Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 2017

Authors and Affiliations

  1. 1.Division of Neurosurgery, St. Michael’s Hospital, Keenan Research Centre for Biomedical Science and the Li Ka Shing Knowledge Institute of St. Michael’s Hospital, Department of SurgeryUniversity of TorontoTorontoCanada
  2. 2.Department of Neurology, University Hospital of EssenUniversity of Duisburg-EssenEssenGermany
  3. 3.Department of Diagnostic and Interventional Radiology, Medical FacultyUniversity of DüsseldorfDüsseldorfGermany
  4. 4.Institute of Neurophysiology, Medical FacultyUniversity of CologneCologneGermany
  5. 5.Department of Neurosurgery, Research Unit for Experimental NeurotraumatologyMedical University GrazGrazAustria

Personalised recommendations